{"id":"W2601029316","doi":"10.1200/jco.2012.30.15_suppl.6605","title":"Analysis of imatinib (IM)-related, low-grade (LG), non-hematologic (heme) adverse events (AEs) in patients (pts) with chronic myeloid leukemia (CML) switched to nilotinib (NIL): ENRICH study update.","year":2012,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"ca_institutions":"Hôpital Maisonneuve-Rosemont; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Internal medicine; Adverse effect; Gastroenterology; Rash; Nilotinib; Hypokalemia; Imatinib mesylate; Imatinib; Myeloid leukemia","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00234115,0.0002531284,0.0007547649,0.0007052258,0.00009731879,0.0006676325,0.0003401779,0.0002422017,0.001173497],"category_scores_gemma":[0.00221083,0.0001417467,0.0006913247,0.001058066,0.0001136994,0.000377904,0.0003580349,0.0002972358,0.0002037702],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004137917,"about_ca_system_score_gemma":0.0004055577,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006315326,"about_ca_topic_score_gemma":0.002098721,"domain_scores_codex":[0.9990581,0.0004002506,0.0001636937,0.0001001155,0.0002299353,0.00004794076],"domain_scores_gemma":[0.9975063,0.0007264161,0.001159064,0.0001447219,0.0002958172,0.0001676605],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.01908528,0.0004899841,0.7952427,0.001994475,0.002929494,0.000142563,0.000126078,0.0007600273,0.005362123,0.0001077734,0.004798227,0.1689612],"study_design_scores_gemma":[0.002253542,0.007650733,0.9683853,0.000198832,0.002840561,0.0007900862,0.00008239311,0.0008043296,0.002830912,0.00009184729,0.01405034,0.0000209793],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9609442,0.02358446,0.001091854,0.0002908455,0.00002798225,0.0004682693,0.01010263,0.00006778427,0.003421945],"genre_scores_gemma":[0.9762099,0.005868508,0.001509006,0.0005100059,0.00007083995,0.0002722117,0.0146487,0.00001517944,0.0008956603],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00234115,"threshold_uncertainty_score":0.01238132,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03651058472077823,"score_gpt":0.3849061967842785,"score_spread":0.3483956120635002,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}